Keith Hoffmaster
- Pharmacology top 1%
- Pharmacogenetics and Drug Metabolism 7
- Drug-Induced Hepatotoxicity and Protection 4
- Oncology top 5%
- Drug Transport and Resistance Mechanisms 11
- Hepatology top 5%
-
- Pharmacological Effects and Toxicity Studies 6
- Infectious Diseases top 10%
- HIV/AIDS drug development and treatment 4
-
- Neuropeptides and Animal Physiology 3
-
- Innovative Microfluidic and Catalytic Techniques Innovation 2
-
- Analytical Chemistry and Chromatography 2
- Co-authors
- Kim L. R. BrouwerMaciej J. Zamek‐GliszczynskiKen-ichi NezasaMelanie N. TallmanRyan Z. TurncliffDaniel A.J. BowDietrich KepplerJohan Palm
- Cited by
- PharmacologyOncologyHepatology
- Journals
- Journal of Pharmacology and Experimental Therapeutics (3 papers)Clinical Pharmacology & Therapeutics (3 papers)Drug Metabolism and Disposition (3 papers)
- Partner nations
- United StatesSwitzerlandNetherlands
In The Last Decade
Keith Hoffmaster
20 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 101
- Pharmacology 409
- Oncology 625
- Hepatology 141
- Pediatrics, Perinatology and Child Health 322
- Infectious Diseases 154
Countries citing papers authored by Keith Hoffmaster
This map shows the geographic impact of Keith Hoffmaster's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Keith Hoffmaster with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Keith Hoffmaster more than expected).
Fields of papers citing papers by Keith Hoffmaster
This network shows the impact of papers produced by Keith Hoffmaster. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Keith Hoffmaster. The network helps show where Keith Hoffmaster may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Keith Hoffmaster, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 18 | |
| 2 | 2014 | 152 | |
| 3 | 2014 | 15 | |
| 4 | 2013 | 191 | |
| 5 | 2012 | 57 | |
| 6 | 2012 | 20 | |
| 7 | 2011 | 127 | |
| 8 | 2009 | 127 | |
| 9 | 2008 | 6 | |
| 10 | 2006 | 195 | |
| 11 | 2006 | 65 | |
| 12 | 2006 | 25 | |
| 13 | 2005 | 54 | |
| 14 | 2004 | 32 | |
| 15 | 2004 | 32 | |
| 16 | 2004 | 121 | |
| 17 | 2002 | 38 | |
| 18 | Bioavailability, multiple-dose pharmacokinetics, and biotransformation of the aldose reductase inhibitor zopolrestat in dogs. | 1998 | 3 |
| 19 | 1997 | 71 | |
| 20 | 1997 | 4 |
About Keith Hoffmaster
Keith Hoffmaster is a scholar working on Pharmacology, Oncology, Pediatrics, Perinatology and Child Health, Hepatology and Modeling and Simulation, having authored 20 papers that have together received 1.4k indexed citations. Recurring topics across this work include Drug Transport and Resistance Mechanisms (11 papers), Pharmacogenetics and Drug Metabolism (7 papers), Pharmacological Effects and Toxicity Studies (6 papers), Drug-Induced Hepatotoxicity and Protection (4 papers), HIV/AIDS drug development and treatment (4 papers), Neuropeptides and Animal Physiology (3 papers), Innovative Microfluidic and Catalytic Techniques Innovation (2 papers) and Analytical Chemistry and Chromatography (2 papers). The work is most often cited by research in Pharmacology (409 citations), Oncology (625 citations), Hepatology (141 citations), Pediatrics, Perinatology and Child Health (322 citations) and Infectious Diseases (154 citations). Keith Hoffmaster has collaborated with scholars based in United States, Switzerland and Netherlands. Frequent co-authors include Kim L. R. Brouwer, Maciej J. Zamek‐Gliszczynski, Ken-ichi Nezasa, Melanie N. Tallman, Ryan Z. Turncliff, Daniel A.J. Bow, Dietrich Keppler, Johan Palm, Yurong Lai and Yaofeng Cheng. Their work appears in journals such as Journal of Pharmacology and Experimental Therapeutics, Clinical Pharmacology & Therapeutics, Drug Metabolism and Disposition, Rapid Communications in Mass Spectrometry and Bioorganic & Medicinal Chemistry Letters.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.